165 related articles for article (PubMed ID: 26561468)
1. Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.
Yousefi F; Siadat SD; Saraji AA; Hesaraki S; Aslani MM; Mousavi SF; Imani Fooladi AA
Tumour Biol; 2016 Apr; 37(4):5305-16. PubMed ID: 26561468
[TBL] [Abstract][Full Text] [Related]
2. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen.
Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA
Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.
Imani Fooladi AA; Halabian R; Mahdavi M; Amin M; Mahmoodzadeh Hosseini H
Tumour Biol; 2016 Jan; 37(1):739-48. PubMed ID: 26245994
[TBL] [Abstract][Full Text] [Related]
4. In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique.
Imani-Fooladi AA; Yousefi F; Mousavi SF; Amani J
Iran J Cancer Prev; 2014; 7(3):152-64. PubMed ID: 25250167
[TBL] [Abstract][Full Text] [Related]
5. TGFαL3-SEB fusion protein as an anticancer against ovarian cancer.
Maleki F; Sadeghifard N; Sedighian H; Bakhtiyari S; Hosseini HM; Fooladi AAI
Eur J Pharmacol; 2020 Mar; 870():172919. PubMed ID: 31935394
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory effects of TGFαL3-SEB chimeric protein on colon cancer cell line.
Maleki F; Sadeghifard N; Hosseini HM; Bakhtiyari S; Goleij Z; Behzadi E; Sedighian H; Imani Fooladi AA
Biomed Pharmacother; 2019 Feb; 110():190-196. PubMed ID: 30471512
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects between Staphylococcal enterotoxin type B and Monophosphoryl lipid A against mouse fibrosarcoma.
Imani Fooladi AA; Sattari M; Reza Nourani M
J BUON; 2010; 15(2):340-7. PubMed ID: 20658733
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
[TBL] [Abstract][Full Text] [Related]
9. In vivo induction of necrosis in mice fibrosarcoma via intravenous injection of type B staphylococcal enterotoxin.
Fooladi AA; Sattari M; Hassan ZM; Mahdavi M; Azizi T; Horii A
Biotechnol Lett; 2008 Dec; 30(12):2053-9. PubMed ID: 18651228
[TBL] [Abstract][Full Text] [Related]
10. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
Schols D; Jones D; Roncarolo MG
J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
[TBL] [Abstract][Full Text] [Related]
11. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
Sundstedt A; Celander M; Hedlund G
Int Immunopharmacol; 2008 Mar; 8(3):442-52. PubMed ID: 18279798
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of a novel superantigen fusion protein: bFGF/SEB.
Wang L; Zhang H; Zhang S; Yu M; Yang X
Cancer Invest; 2009 May; 27(4):376-83. PubMed ID: 19160106
[TBL] [Abstract][Full Text] [Related]
13. Superantigen and endotoxin synergize in the induction of lethal shock.
Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
[TBL] [Abstract][Full Text] [Related]
14. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B.
Shinbori T; Matsuki M; Suga M; Kakimoto K; Ando M
Cell Immunol; 1996 Dec; 174(2):129-37. PubMed ID: 8954612
[TBL] [Abstract][Full Text] [Related]
15. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
Okamoto S; Kawabata S; Nakagawa I; Hamada S
Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
[TBL] [Abstract][Full Text] [Related]
16. Role and regulation of IL-12 in the in vivo response to staphylococcal enterotoxin B.
Muraille E; Pajak B; Urbain J; Moser M; Leo O
Int Immunol; 1999 Sep; 11(9):1403-10. PubMed ID: 10464161
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10.
Crisi GM; Santambrogio L; Hochwald GM; Smith SR; Carlino JA; Thorbecke GJ
Eur J Immunol; 1995 Nov; 25(11):3035-40. PubMed ID: 7489740
[TBL] [Abstract][Full Text] [Related]
19. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.
Matthys P; Mitera T; Heremans H; Van Damme J; Billiau A
Infect Immun; 1995 Apr; 63(4):1158-64. PubMed ID: 7890366
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
